Ticlopidine Hydrochloride (Carilion Materials Management)


Welcome to the PulseAid listing for the Ticlopidine Hydrochloride drug offered from Carilion Materials Management. This Decreased Platelet Aggregation [PE],Platelet Aggregation Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Carilion Materials Management
NON-PROPRIETARY NAME: Ticlopidine Hydrochloride
SUBSTANCE NAME: TICLOPIDINE HYDROCHLORIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Decreased Platelet Aggregation [PE],Platelet Aggregation Inhibitor [EPC]
ROUTE: ORAL
DOSAGE FORM: TABLET, FILM COATED
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 1999-09-07
END MARKETING DATE: 0000-00-00


Ticlopidine Hydrochloride HUMAN PRESCRIPTION DRUG Details:

Item DescriptionTiclopidine Hydrochloride from Carilion Materials Management
LABELER NAME: Carilion Materials Management
DEA SCHEDULE:
ACTIVE STRENGTH: 250(mg/1)
START MARKETING DATE: 1999-09-07
END MARKETING DATE: 0000-00-00
PRODUCT ID: 68151-0079_c01a9760-cfb9-4d0d-9cf6-12d9deff463f
PRODUCT NDC: 68151-0079
APPLICATION NUMBER: ANDA075149

Other TICLOPIDINE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Apotex Corp.Ticlopidine hydrochloride
Caraco Pharmaceutical Laboratories, Ltd.Ticlopidine Hydrochloride
Carilion Materials ManagementTiclopidine Hydrochloride
Eon Labs, Inc.Ticlopidine Hydrochloride